Previous Close | 0.2900 |
Open | 0.2564 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.2200 - 0.2800 |
52 Week Range | 0.2200 - 37.2000 |
Volume | |
Avg. Volume | 7,801 |
Market Cap | 206,084 |
Beta (5Y Monthly) | 0.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -11.0000 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.25 |
STONY BROOK, NY / ACCESSWIRE / April 22, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock, to be effective ...
- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods - - Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea™ DNA IVT Templates - STONY BROOK, NY and JUPITER, FL / ACCESSWIRE ...
STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea™ IVT and Linea™ DNA platforms at the 24th Annual World Vaccine Congress, which ...